Sun Pharma Stock Up, Settles Patent Litigation For Generic Revlimid

Sun Pharmaceutical Industries Limited along with one of its wholly owned subsidiaries today announced that they have reached an agreement with Celgene Corporation (Celgene), a wholly-owned subsidiary of Bristol Myers Squibb, to resolve the patent litigation regarding submission of an Abbreviated

from Latest Business News | Finance News India | International Share Market – Oneindia Money https://ift.tt/35HjOjV